[Israel Business Series] Can Data Predict Life or Death Medical Care Before the Patient Shows Signs? With Gal Salomon CEO of CLEW Medical

43:03
 
Share
 

Manage episode 273486642 series 83869
By Dr. Jeremy Weisz. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Gal Salomon is the CEO and Founder of CLEW Medical, a company that uses artificial intelligence and predictive analytics to improve the outcome of critically ill patients. They help doctors predict who needs life or death medical care before they’re needed.

Before founding CLEW Medical, Gal founded Sansa Security and led the company as CEO until 2010. He then served as the Chairman of the Board until the acquisition of ARM. During this time, he was also a Venture Partner at Pitango Venture Capital. Gal has also previously served in multiple positions at Intel and DSP Communications.

In this episode…

Imagine losing a loved one because of an avoidable healthcare mistake. When health professionals fail to react on time and pay attention to detail, it can lead to a devastating loss that no one can really prepare for. Gal Salomon experienced this kind of loss when he lost his mother when healthcare workers failed to respond quickly to her needs. And Gal took it upon himself to find a technological solution to help doctors predict who needs life or death medical care before they’re actually needed.

Bringing new solutions in the healthcare industry is extremely difficult, especially as when you’re an outsider. But Gal managed to find a work around the initial resistance and founded CLEW Medical.

On this episode of Inspired Insider Dr. Jeremy Weisz talks with the CEO and Founder of CLEW Medical, Gal Salomon, about his inspiration for starting his company and what they do to help save lives. Gal also shares how they utilize artificial intelligence and predictive analytics to improve the outcomes for critically ill patients, how they pushed back against the initial objections they faced, and the process they had to go through to get FDA clearance. Stay tuned.

745 episodes